Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

NCT04440267 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia of Ambiguous Lineage

Interventions

DRUG: vincristine
DRUG: daunorubicin
DRUG: cyclophosphamide
DRUG: L-Asparaginase
DRUG: prednisone
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: dexamethasone
DRUG: Tyrosine kinase inhibitor

Sponsor

Institute of Hematology & Blood Diseases Hospital, China